Multiparametric evaluation of the effects of dapagliflozin in patients with heart failure and reduced ejection fraction
This prospective, multiparametric study showed that the additional administration of dapaglifozin to sacubitril/valsartan and other HF drugs is effective after three months.
Authors
- Michele Di Mauro (ORCID: https://orcid.org/0000-0003-2611-5626)
- Stefania Martano
- Alessandro Mandurino‐Mirizzi (ORCID: https://orcid.org/0000-0003-4162-5384)
- M Donateo
- Filippo M. Sarullo (ORCID: https://orcid.org/0000-0003-2046-8316)
- Giovanni Colonna (ORCID: https://orcid.org/0000-0002-0473-1455)
- Alessandro Cafaro (ORCID: https://orcid.org/0000-0002-2068-7351)
- Alexandra R. Leonardo
- Francesca Sturdà (ORCID: https://orcid.org/0000-0003-3480-6806)
- Giuseppe Chiariello
- Antonio De Pascalis (ORCID: https://orcid.org/0000-0003-1685-7263)
- Stefania Marazìa
- Erika Pedio
- Ana Carla
Institutions
- Cardiovascular Institute Hospital (JP)
- Maastricht University (NL)
- Fatebenefratelli Hospital (IT)
- Casa di cura Pierangeli (IT)
- Ospedale Vito Fazzi (IT)
- Ospedale Buccheri la Ferla Fatebenefratelli (IT)
Publication Details
- Journal
- Acta cardiologica. Supplementum
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1080/00015385.2025.2569024
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29